Literature DB >> 9493370

Streptococcus suis serotype 2 mutants deficient in capsular expression.

N Charland1, J Harel, M Kobisch, S Lacasse, M Gottschalk.   

Abstract

Streptococcus suis serotype 2 is responsible for a wide variety of porcine infections. In addition, it is considered a zoonotic agent. Knowledge about the virulence factors for this bacterium is limited but its polysaccharide capsule is thought to be one of the most important. Transposon mutagenesis with the self-conjugative transposon Tn916 was used to obtain acapsular mutants from the virulent S. suis type 2 reference strain S735. Clones were screened by colony-dot ELISA with a monoclonal antibody specific for a type 2 capsular epitope and clones that failed to react with the antibody were characterized. Two mutants, 2A and 79, having one and two Tn916 insertions respectively, were chosen for further characterization. Absence of capsule was confirmed by coagglutination, capillary precipitation and capsular reaction tests and by transmission electron microscopy. Absence of capsular polysaccharides correlated with increased hydrophobicity and phagocytosis by both murine macrophages and porcine monocytes compared to the wild-type strain. Furthermore, both mutants were shown to be avirulent in murine and pig models of infection. Finally, mutant 2A was readily eliminated from circulation in mice compared to the wild-type strain, which persisted more than 48 h in blood. Thus, isogenic mutants defective in capsule production demonstrate the importance of capsular polysaccharides as a virulence factor for S. suis type 2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9493370     DOI: 10.1099/00221287-144-2-325

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  60 in total

1.  Dilemma of the virulence of Strptococcus suis strains.

Authors:  M Gottschalk; R Higgins; S Quessy
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Selection of virulence-associated determinants of Streptococcus suis serotype 2 by in vivo complementation.

Authors:  H E Smith; H Buijs; H J Wisselink; N Stockhofe-Zurwieden; M A Smits
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Role of capsule and suilysin in mucosal infection of complement-deficient mice with Streptococcus suis.

Authors:  Maren Seitz; Andreas Beineke; Alena Singpiel; Jörg Willenborg; Pavel Dutow; Ralph Goethe; Peter Valentin-Weigand; Andreas Klos; Christoph G Baums
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

4.  Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells.

Authors:  N Charland; V Nizet; C E Rubens; K S Kim; S Lacouture; M Gottschalk
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  In vitro characterization of the microglial inflammatory response to Streptococcus suis, an important emerging zoonotic agent of meningitis.

Authors:  María de la Cruz Domínguez-Punaro; Mariela Segura; Irazú Contreras; Claude Lachance; Mathieu Houde; Marie-Pier Lecours; Martin Olivier; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

6.  Acquisition of host plasmin activity by the Swine pathogen Streptococcus suis serotype 2.

Authors:  Marie-Claude Jobin; Julie Brassard; Sylvain Quessy; Marcelo Gottschalk; Daniel Grenier
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Dynamic Virus-Bacterium Interactions in a Porcine Precision-Cut Lung Slice Coinfection Model: Swine Influenza Virus Paves the Way for Streptococcus suis Infection in a Two-Step Process.

Authors:  F Meng; N H Wu; A Nerlich; G Herrler; P Valentin-Weigand; M Seitz
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

8.  Characterization of the invasion of porcine endothelial cells by Streptococcus suis serotype 2.

Authors:  Ghyslaine Vanier; Mariela Segura; Marcelo Gottschalk
Journal:  Can J Vet Res       Date:  2007-04       Impact factor: 1.310

9.  Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis.

Authors:  Mariela Segura; Marcelo Gottschalk; Martin Olivier
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Identification of a novel host-specific IgM protease in Streptococcus suis.

Authors:  Jana Seele; Alena Singpiel; Christian Spoerry; Ulrich von Pawel-Rammingen; Peter Valentin-Weigand; Christoph G Baums
Journal:  J Bacteriol       Date:  2012-12-14       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.